<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38633559</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>19</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2667-646X</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Infectious diseases &amp; clinical microbiology</Title><ISOAbbreviation>Infect Dis Clin Microbiol</ISOAbbreviation></Journal><ArticleTitle>Long-Term Symptoms and Quality of Life in Persons with COVID-19.</ArticleTitle><Pagination><StartPage>212</StartPage><EndPage>220</EndPage><MedlinePgn>212-220</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.36519/idcm.2023.248</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">After three years since the first cases of COVID-19, many people suffer from post-COVID symptoms, reducing their quality of life. In this study, we aimed to evaluate the symptoms and prevalence of long COVID and its effect on the quality of life and also the effect of SARS-CoV-2 vaccine on the quality of life.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="UNASSIGNED">Patients with COVID-19 between April 01, 2020, and December 31, 2021, were evaluated with a survey at least three and at most 12 months (mean 7.43&#xb1;3.3 months) after diagnosis. Patients answered the questions face-to-face or via telephone interview. The survey included questionnaires on demographic features, current complaints, and complaints that persisted or developed after recovery, Short Form 36 Health Survey (SF-36), and European Quality of Life 5 Dimensions 3 Level Version (EQ-5D-3L) Scale.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The study was conducted with 521 participants, 81% complaining of post-COVID symptoms. The most common symptoms were fatigue and shortness of breath. Long COVID was found to significantly reduce the quality of life in both sub-dimensions of the scale. Compared to SF-36 Turkish population norms, all participants showed a significant decrease in quality of life subscales. Vaccination against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was found to improve quality of life and reduce long-term COVID-19 symptoms.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">COVID-19 has significantly affected quality of life. Post-illness follow-up of people with COVID-19 is important to provide patients with medical, physical, and psychosocial rehabilitation support. SARS-COV-2 vaccine reduces the negative effects of COVID-19 on quality of life. For this reason, the community should be made aware of vaccination, and COVID-19 vaccination rates should be increased in the community.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Infectious Diseases and Clinical Microbiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yal&#xe7;&#x131;n-&#xc7;olak</LastName><ForeName>Nuriye</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-3569-8165</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases and Clinical Microbiology, Yozgat Bozok University School of Medicine, Yozgat, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kader</LastName><ForeName>&#xc7;i&#x11f;dem</ForeName><Initials>&#xc7;</Initials><Identifier Source="ORCID">0000-0003-3325-4587</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases and Clinical Microbiology, Yozgat Bozok University School of Medicine, Yozgat, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eren-G&#xf6;k</LastName><ForeName>&#x15e;ebnem</ForeName><Initials>&#x15e;</Initials><Identifier Source="ORCID">0000-0002-0549-6530</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases and Clinical Microbiology, Yozgat Bozok University School of Medicine, Yozgat, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erbay</LastName><ForeName>Ay&#x15f;e</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8882-4124</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases and Clinical Microbiology, Yozgat Bozok University School of Medicine, Yozgat, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Turkey</Country><MedlineTA>Infect Dis Clin Microbiol</MedlineTA><NlmUniqueID>9918680988406676</NlmUniqueID><ISSNLinking>2667-646X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">quality of life</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>18</Day><Hour>4</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38633559</ArticleId><ArticleId IdType="pmc">PMC10985820</ArticleId><ArticleId IdType="doi">10.36519/idcm.2023.248</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Current ICTV taxonomy release. International Committee on Taxonomy of Viruses (ICTV)  [September
12, 2023]. 
https://ictv.global/taxonomy</Citation></Reference><Reference><Citation>COVID-19 (SARS-Cov-2 Infection): General Information,
Epidemiology and Diagnosis, December 7, 2020. Ankara: Republic of Turkey Ministry of Health General Directorate of
Public Health.  [May 9,
2023]. 
https://covid19.saglik.gov.tr/Eklenti/39551/0/covid-19rehberigenelbilgilerepidemiyolojivetanipdf.pdf</Citation></Reference><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard. Geneva: World Health Organization.  [September
12, 2023]. 
https://covid19.who.int/</Citation></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. 2022;23(2):194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) 2021;53(10):737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimeno-Almaz&#xe1;n A, Pallar&#xe9;s JG, Buend&#xed;a-Romero &#xc1;, Mart&#xed;nez-Cava A, Franco-L&#xf3;pez F, S&#xe1;nchez-Alcaraz Mart&#xed;nez BJ, et al. Post-COVID-19 syndrome and the potential benefits of exercise. Int J Environ Res Public Health. 2021;18(10) doi: 10.3390/ijerph18105329.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18105329</ArticleId><ArticleId IdType="pmc">PMC8156194</ArticleId><ArticleId IdType="pubmed">34067776</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pubmed">1593914</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko&#xe7;yi&#x11f;it H, Aydemir &#xd6;, Fi&#x15f;ek G, &#xd6;lmez N, Memi&#x15f; AK. Form-36 (KF-36)'n&#x131;n T&#xfc;rk&#xe7;e versiyonunun g&#xfc;venilirli&#x11f;i ve ge&#xe7;erlili&#x11f;i. Ila&#xe7; ve Tedavi Derg. 1999;12:102&#x2013;106.</Citation></Reference><Reference><Citation>Wise J. Long covid: WHO calls on countries to offer patients more rehabilitation. BMJ. 2021;372:n405. doi: 10.1136/bmj.n405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n405</ArticleId><ArticleId IdType="pubmed">33568362</ArticleId></ArticleIdList></Reference><Reference><Citation>Healthcare workers: Information on COVID-19. Atlanta: Centers for Disease Control and Prevention (CDC)  [November
14, 2022]. 
https://www.cdc.gov/coronavirus/2019-ncov/hcp/</Citation></Reference><Reference><Citation>Nalbandian A, Desai AD, Wan EY. Post-COVID-19 condition. Annu Rev Med. 2023;74:55&#x2013;64. doi: 10.1146/annurev-med-043021-030635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-043021-030635</ArticleId><ArticleId IdType="pubmed">35914765</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu&#xf1;oz-Corona C, Guti&#xe9;rrez-Canales LG, Ortiz-Ledesma C, Mart&#xed;nez-Navarro LJ, Mac&#xed;as AE, Scavo-Montes DA, et al. Quality of life and persistence of COVID-19 symptoms 90 days after hospital discharge. J Int Med Res. 2022;50(7) doi: 10.1177/03000605221110492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03000605221110492</ArticleId><ArticleId IdType="pmc">PMC9284218</ArticleId><ArticleId IdType="pubmed">35822272</ArticleId></ArticleIdList></Reference><Reference><Citation>Taboada M, Moreno E, Cari&#xf1;ena A, Rey T, Pita-Romero R, Leal S, et al. Quality of life, functional status, and persistent symptoms after intensive care of COVID-19 patients. Br J Anaesth. 2021;126(3):110&#x2013;113. doi: 10.1016/j.bja.2020.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.12.007</ArticleId><ArticleId IdType="pmc">PMC7833644</ArticleId><ArticleId IdType="pubmed">33413976</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: A systematic review. JAMA Netw Open. 2021;4(5):e2111417. doi: 10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Durmaz A, Y&#x131;lmaz M. Long-Covid: What awaits us after corona infection? J Basic Clin Health Sci. 2022;6(3):743&#x2013;753. doi: 10.30621/jbachs.1021549.</Citation><ArticleIdList><ArticleId IdType="doi">10.30621/jbachs.1021549</ArticleId></ArticleIdList></Reference><Reference><Citation>Desgranges F, Tadini E, Munting A, Regina J, Filippidis P, Viala B, the RegCOVID Research Group et al. Post-COVID-19 Syndrome in Outpatients: a Cohort Study. J Gen Intern Med. 2022;37(8):1943&#x2013;1952. doi: 10.1007/s11606-021-07242-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-021-07242-1</ArticleId><ArticleId IdType="pmc">PMC8939498</ArticleId><ArticleId IdType="pubmed">35319081</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xed;&#x161;ka D, Liptakov&#xe1; E, Babi&#x10d;ov&#xe1; A, Batalik L, Ba&#x148;&#xe1;rov&#xe1; PS, Dobrodenkov&#xe1; S. What is the quality of life in patients with long COVID compared to a healthy control group? Front Public Health. 2022;10 doi: 10.3389/fpubh.2022.975992.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.975992</ArticleId><ArticleId IdType="pmc">PMC9667067</ArticleId><ArticleId IdType="pubmed">36408018</ArticleId></ArticleIdList></Reference><Reference><Citation>Demiral Y, Ergor G, Unal B, Semin S, Akvardar Y, Kivircik B, et al. Normative data and discriminative properties of short form 36 (SF-36) in Turkish urban population. BMC Public Health. 2006;6 doi: 10.1186/1471-2458-6-247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-6-247</ArticleId><ArticleId IdType="pmc">PMC1615878</ArticleId><ArticleId IdType="pubmed">17029646</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu G, Zhen Q, Wang W, Fan S, Wu Q, Zhang C, et al. Health-related quality of life of COVID-19 patients after discharge: A multicenter follow-up study. J Clin Nurs. 2021;30(11-12):1742&#x2013;1750. doi: 10.1111/jocn.15733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocn.15733</ArticleId><ArticleId IdType="pmc">PMC8013595</ArticleId><ArticleId IdType="pubmed">33656210</ArticleId></ArticleIdList></Reference><Reference><Citation>Todt BC, Szlejf C, Duim E, Linhares AOM, Kogiso D, Varela G, et al. Clinical outcomes and quality of life of COVID-19 survivors: A follow-up of 3 months post hospital discharge. Respir Med. 2021;184:106453. doi: 10.1016/j.rmed.2021.106453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106453</ArticleId><ArticleId IdType="pmc">PMC8116128</ArticleId><ArticleId IdType="pubmed">34010740</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. Journal of Infection. 2020;81(6):e4-e6. doi: 10.1016/j.jinf.2020.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>